Page last updated: 2024-08-24

gemcitabine and kaempferol

gemcitabine has been researched along with kaempferol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Banerjee, N; Basu, S; Bhattacharya, R; Chatterjee, K; Chattopadhyay, S; Choudhury, P; Mukhopadhyay, A; Mukhopadhyay, S; Nandi, SK; Roychowdhury, T; Saha, P	1

Other Studies

1 other study(ies) available for gemcitabine and kaempferol

Article	Year
Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil. Toxicology and applied pharmacology, 2022, 02-15, Volume: 437 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Female; Gemcitabine; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Kaempferols; Nanog Homeobox Protein; Neoplastic Stem Cells; Verapamil	2022

Article

Year

Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil.

Toxicology and applied pharmacology, 2022, 02-15, Volume: 437

Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Female; Gemcitabine; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Kaempferols; Nanog Homeobox Protein; Neoplastic Stem Cells; Verapamil

2022